Mesa Laboratories (NASDAQ:MLAB) Issues Quarterly Earnings Results

Mesa Laboratories (NASDAQ:MLAB) announced its quarterly earnings data on Tuesday. The medical instruments supplier reported $2.07 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.66, Zacks reports. Mesa Laboratories had a positive return on equity of 28.52% and a negative net margin of 107.56%.

Mesa Laboratories Stock Up 1.2 %

NASDAQ:MLAB opened at $138.90 on Thursday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.51 and a current ratio of 0.70. Mesa Laboratories has a 12 month low of $83.68 and a 12 month high of $152.75. The company’s 50-day moving average price is $133.67 and its two-hundred day moving average price is $125.66.

Mesa Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Friday, February 28th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, February 28th. This represents a $0.64 annualized dividend and a yield of 0.46%. Mesa Laboratories’s dividend payout ratio is currently -1.40%.

Analyst Ratings Changes

Separately, StockNews.com lowered shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a report on Wednesday, November 13th.

About Mesa Laboratories

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.